One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission

British Journal of Haematology

Volumn 129, Issue 3, 2005, Pages 403-410

  Jourdan, Eric ^a   Rigal Huguet, Françoise ^b   Marit, Gerald ^c   Vey, Norbert ^d   Dastugue, Nicole ^b   Fegueux, Nathalie ^e   Molina, Lysiane ^f   Gastaut, Jean Albert ^d   Legros, Laurence ^g   Zerazhi, Hacene ^h   Cailleres, Sylvie ⁱ   Bauduer, Frédéric ^j   Bordessoule, Dominique ^k   Attal, Michel ^b   Blaise, Didier ^d   Pigneux, Arnaud ^c  

^a DEPARTMENT OF NEUROLOGY   (France)

^b CHU PURPAN   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f HÔPITAL MICHALLON   (France)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^h CENTRE HOSPITALIER D AVIGNON   (France)

ⁱ CH d'Aix en Provence ^*  (France)

^j Renal Unit Hôpital de la Côte Basque   (France)

^k DUPUYTREN UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Acute myeloid leukaemia; High dose cytarabine; Stem cell transplantation

Indexed keywords

BUSULFAN; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MELPHALAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER INCIDENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 20844442475     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05470.x     Document Type: Article

References (18)

1. Burnett, A.K., Goldstone, A.H., Stevens, R.M., Hann, I.M., Rees, J.K., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet, 351, 700-708.
2. Cassileth, P.A., Harrington, D.P., Appelbaum, F.R., Lazarus, H.M., Rowe, J.M., Paietta, E., Willman, C., Hurd, D.D., Bennett, J.M., Blume, K.G., Head, D.R. & Wiernik, P.H. (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. New England Journal of Medicine, 339, 1649-1656.
3. Cox, D. (1972) Regression models and life tables. Journal of the Royal Statistical Soceity B, 34, 187-220.
4. Gorin, N.C., Labopin, M., Fouillard, L., Meloni, G., Frassoni, F., Iriondo, A., Brunet Mauri, S., Goldstone, A.H., Harousseau, J.L., Reiffers, J., Esperou-Bourdeau, H. & Gluckman, E. (1996) Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 18, 111-117.
5. Harousseau, J.L., Cahn, J.Y., Pignon, B., Witz, F., Milpied, N., Delain, M., Lioure, B., Lamy, T., Desablens, B., Guilhot, F., Caillot, D., Abgrall, J.F., Francois, S., Briere, J., Guyotat, D., Casassus, P., Audhuy, B., Tellier, Z., Hurteloup, P. & Herve, P. (1997) Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood, 90, 2978-2986.
6. ISCN (1995) An International System for Human Cytogenetic Nomenclature (1995): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Memphis, Tennessee, October 1994 (ed. by F. Mitelman). S. Karger, Basel, Switzerland.
7. Kaplan, E.L. & Meier, P. (1958) Non parametric estimation from incomplete observations. Journal of American Statistical Association, 53, 457-481.
8. Klabfleisch, J. & Prentice, R. (1980) The Statistical Analysis of Failure Time Data. Wiley, New York.
9. McMillan, A.K., Goldstone, A.M., Linch, D.C., Gribben, J.G., Patterson, K.G., Richards, J.D., Franklin, I., Boughton, B.J., Milligan, D.W. & Leyland, M.M. (1990) High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood, 76, 480-488.
10. Miggiano, M.C., Gherlinzoni, F., Rosti, G., Bandini, G., Visani, G., Fiacchini, M., Ricci, P., Testoni, N., Motta, M.R., Geromin, A., Rizzi, S., Belardinelli, A., Mangianti, S., Manfroi, S. & Tura, S. (1996) Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. Leukemia, 10, 402-409.
11. Nathan, P.C., Sung, L., Crump, M. & Beyene, J. (2004) Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis. Journal of the National Cancer Institute, 96, 38-45.
12. Peto, R. & Peto, J. (1972) Asymptomatically efficient rank invariant test procedures. Journal of the Royal Statistical Society, Series A, 135, 185-198.
13. Reiffers, J., Gaspard, M.H., Maraninchi, D., Michallet, M., Marit, G., Stoppa, A.M., Corront, B., David, B., Gastaut, J.A., Scotto, J.J., Broustet, A., Carcassonne, Y. & Hollard, D. (1989) Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. British Journal of Haematology, 72, 57-63.
14. Reiffers, J., Stoppa, A.M., Attal, M., Michallet, M., Marit, G., Biaise, D., Huguet, F., Corront, B., Cony-Makhoul, P., Gastaur., J.A., Laurent, G., Molina, L., Broustet, A., Maraninchi, D., Pris, J., Hollard, D. & Faberes, C. (1996) Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study. Leukemia, 10, 1874-1882.
15. Sanz, M.A., de la Rubia, J., Sanz, G.F., Martin, G., Martinez, J., Jarque, I., Sempere, A., Gomis, F., Senent, L. & Soler, M.A. (1993) Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. Journal of Clinical Oncology, 11, 1661-1667.
16. Stein, A.S., O'Donnell, M.R., Chai, A., Schmidt, G.M., Nademanee, A., Parker, P.M., Smith, E.P., Snyder, D.S., Molina, A., Stepan, D.E., Spielberger, R., Somlo, G., Margolin, K.A., Vora, N., Lipsett, J., Lee, J., Niland, J. & Forman, S.J. (1996) In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. Journal of Clinical Oncology, 14, 2206-2216.
17. Wheatley, K. (2002) Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? - a statistician's view. British Journal of Haematology, 118, 351-356.
18. Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Stryckmans, P., Rotoli, B., Leoni, P., Peetermans, M.E., Dardenne, M., Vegna, M.L., Petti, M.C., Solbu, G. & Suciu, S. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. New England Journal of Medicine, 332, 217-223.